Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Stem Cells

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.2636PMID 28480563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered

  2017cited by this paper
• Intrastriatal Transplantation of Human Neural Stem Cells Restores the Impaired Subventricular Zone in Parkinsonian Mice

  2017cited by this paper
• Engrams and circuits crucial for systems consolidation of a memory

  2017cited by this paper
• Age of PISCES: stem-cell clinical trials in stroke.

  2016cited by this paper
• Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain

  2016cited by this paper
• Recent Advances in Stem Cell-Based Therapeutics for Stroke

  2016cited by this paper
• Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.

  2016cited by this paper
• Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor‐KappaB Signaling

  2016cited by this paper
• Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.

  2016cited by this paper
• Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models

  2016cited by this paper
• Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

  2014cited by this paper
• Bidirectional switch of the valence associated with a hippocampal contextual memory engram

  2014cited by this paper
• Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

  2014cited by this paper
• Stem Cell Recruitment of Newly Formed Host Cells via a Successful Seduction? Filling the Gap between Neurogenic Niche and Injured Brain Site

  2013cited by this paper
• New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease.

  2013cited by this paper
• Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.

  2012cited by this paper
• Autologous Bone Marrow Mononuclear Cell Therapy for Severe Traumatic Brain Injury in Children

  2011cited by this paper
• Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease

  2011cited by this paper
• The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond.

  2010cited by this paper
• Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells

  2007cited by this paper
• Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease

  2006cited by this paper
• Neural transplantation for the treatment of Parkinson's disease.

  2003cited by this paper
• Dyskinesias following neural transplantation in Parkinson's disease

  2002cited by this paper
• Neural transplantation for treatment of Parkinson's disease.

  2002cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Transplantation of cultured human neuronal cells for patients with stroke.

  2001cited by this paper
• Cell therapy in Parkinson's disease – stop or go?

  2001cited by this paper
• Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.

  2000cited by this paper
• Transplantation therapy for Parkinson’s disease

  2000cited by this paper
• Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

  2000cited by this paper
• Neural transplantation for neurodegenerative disorders.

  1999cited by this paper
• Survival of expanded dopaminergic precursors is critical for clinical trials

  1998cited by this paper
• Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

  1997cited by this paper
• Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats

  1997cited by this paper
• Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain

  1996cited by this paper
• Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

  1995cited by this paper
• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  1995cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants

  1992cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

  1989cited by this paper
• Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system.

  1979cited by this paper
• Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.

  1974cited by this paper
• Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

  1970cited by this paper
• Mechanisms Underlying the Impairment of Hippocampal Long-term Potentiation and Memory in Experimental Parkinson's Disease Materials and Methods Procedure for L-dopa Treatments Immunohistological Procedure Behavioural Procedure

  year unknowncited by this paper

• Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson’s disease in rats

  2025influential citation
• Advances in research on biomaterials and stem cell/exosome-based strategies in the treatment of traumatic brain injury

  2025cites this paper
• Probing Gut Participation in Parkinson’s Disease Pathology and Treatment via Stem Cell Therapy

  2023cites this paper
• Neuroprotective Effects of the Neural-Induced Adipose-Derived Stem Cell Secretome against Rotenone-Induced Mitochondrial and Endoplasmic Reticulum Dysfunction

  2023cites this paper
• Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease

  2022cites this paper
• Role of IL-6 in the regulation of neuronal development, survival and function.

  2021cites this paper
• Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke

  2021cites this paper
• Induced neural stem cells from human patient-derived fibroblasts attenuate neurodegeneration in Niemann-Pick type C mice

  2021cites this paper
• Stem Cells for Aging-Related Disorders

  2021cites this paper
• Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury

  2020cites this paper
• Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums.

  2019cites this paper
• Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model

  2019cites this paper
• Stem Cell Therapy: Repurposing Cell-Based Regenerative Medicine Beyond Cell Replacement.

  2018cites this paper
• Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease

  2018cites this paper
• Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson’s disease

  2018cites this paper
• Novel Approach to Stem Cell Therapy in Parkinson's Disease

  2018cites this paper
• Plastic Adaptation: A Neuronal Imperative Capable of Confounding the Goals of Stem Cell Replacement Therapy for either Huntington’s or Parkinson’s Disease

  2017cites this paper
• Improvement of spatial memory of male parkinsonian rats after treatment with adipose stem cells and rosemary leaf extract

  2017cites this paper
• Functional repertoire of interleukin-6 in the central nervous system – a review

  2017cites this paper
• Digital Commons @ University of South Florida Digital Commons @ University of South Florida

  year unknowncites this paper